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ObituaryMary Frances Lyon (1925–2014)Mary Frances LyonMary Lyon was one of the most notable
geneticists of the 20th century. She is
renowned for her discovery of X inacti-
vation, an early example of epigenetic
gene regulation, but she alsomade funda-
mental contributions to the entire field of
genetics.
Mary was born on May 15, 1925 in
Norwich, in the rural east of the United
Kingdom. She was the first child of
Clifford James Lyon, a civil servant, and
Louise Frances Lyon (nee Kirby), a former
school teacher. When she was 10, Mary’s
family, which by then included a younger
brother and sister, moved to Birmingham.
There, she attended King Edward VI High
School for Girls and began her scientific
career, like so many of us, through an
inspirational teacher who made lessons
interesting: Mary Udall, whom Mary
described as having ‘‘a clear analytical
mind.’’ Mary was fascinated by physics
and chemistry, but the prize she received
from an essay competition, four books
on nature study, ultimately led to her
becoming a world-class biologist.
The Second World War helped change
the status of women, and Mary decided
to take the unusual step of reading natural
sciences at the University of Cambridge
(Girton College), where women took the
same coursework as men but at that
time were awarded only titular degrees.
She focused on zoology and became
interested in experimental embryology,
graduating in 1946 with her titular degree.
Rather unusually, she went on to Ph.D
studies with R.A. Fisher, the Balfour Chair
of Genetics at Cambridge, who founded
much of the field of statistics and devel-
oped analysis methods for early gene
linkage studies.
R.A. Fisher was in his fifties—brilliant,
eccentric, and difficult. He threw out
many who joined his lab, but he led Mary
directly to her lifelong study of mouse
genetics. At the time, there was no
systematic method of mapping mouse
genes. With 20 mouse chromosomes,
Fisher decided that, if he crossed all
possible combinations of his 21 visible
mouse mutants, he would likely detect a
new linkage. Students were each given a
line of mice carrying five mutations, and
Mary took on line 18, which included the‘‘pallid’’ mutation. Already an insightful
experimentalist, Mary was unconvinced
that her mouse-crossing experiments
would give her enough data for a Ph.D,
but she noticed that pallid mice tended
to tip their heads to one side. She found
that they were missing otoliths in the inner
ear and went on to investigate the effects
of penetrance and to work out how otolith
absence correlated with postural reflexes.
Meanwhile, Mary was reading books by
Conrad Waddington, known as the father
of epigenetics, and became aware of the
novel idea that embryonic development
depends on genes—at a time when the
exact nature of a gene was unknown.
R.A. Fisher was not interested in develop-
mental genetics, and Mary needed facil-
ities for histology; so as Waddington had
returned from his wartime post (scientific
advisor to the Royal Air Force) to become
Professor of Animal Genetics at the
University of Edinburgh, Mary moved to
his department and to a new supervisor,
Douglas Falconer.
Waddington and Falconer were impor-
tant influences on Mary; she chose to
stay in mouse genetics due to the rele-
vance to human studies. Waddington
applied to the Medical Research Council
(MRC)—which unlike other funders
awarded equal pay for women—and
gained postdoctoral funding for Mary toCell 160,stay in Edinburgh with Toby Carter, work-
ing on the inherited genetic risks from
exposure to ionizing radiation, an area of
great concern after WWII. Several novel
mutants came out of this research, but fa-
cilities were not available for the amount
of mouse breeding required, so in 1955,
the entire mouse group moved to the
MRC Radiobiological Research Unit at
Harwell, led by John Loutit. There, Mary
worked for an astonishingly productive
period spanning more than 50 years. In
the late 1950s, much of her research
centered on the novel chromosome
translocations from the Edinburgh muta-
genesis work, working with Carter, Tony
Searle, and one of the early great cyto-
geneticists, Charles Ford.
Mary knew about X-linked mouse
mutants since her Edinburgh days, and
at Harwell she focused on mottled mu-
tants, in which females have patches of
two different coat colors. She noted that
males either died in embryogenesis
or had a single coat color. However, one
mouse grabbed her attention (ironically,
a spontaneous mutant, not a radiation
mutant): a mottled male. Mary bred this
male and realized that, if a mutation had
occurred when he was an embryo of just
a few cells, he would be a mosaic of
mutated and normal X chromosomes.
Her analysis led to the discovery that
this could also apply to his mottled
daughters, who had two types of cells:
one with an active gene and one without.
Mary’s knowledge that female mice
(unlike female humans) need only one
X chromosome for normal development
and have sex chromatin in their nuclei
led her straight to the work of Susumo
Ohno, whom she regarded as an excep-
tionally creative and gifted scientist, and
his discovery that the sex chromatin was
a condensed X chromosome. Mary had
already considered the idea that only
one X chromosome is active in females,
but her analysis of the mottled mouse,
in the light of Ohno’s discovery, led her
to publish her X inactivation hypothesis
in Nature in 1961.
This concept, now often referred to
as lyonization, was not greeted with
universal applause. Hans Gruneberg,
a distinguished geneticist who madeFebruary 12, 2015 ª2015 Elsevier Inc. 577
important contributions to understanding
human disease through mouse genetics,
simplydidnotbelieve theX inactivationhy-
pothesis. Partly, it made no sense to have
patches of inactivated cells (we now know
that these are clones from early inactiva-
tion events), and partly he may have
thought that Mary was too young and un-
known to have such a fundamental insight.
Gruneberg (a clever man, whose papers
are worth re-reading) was 18 years older
than Mary, well-known, and had been
made a Fellow of the Royal Society (FRS)
in 1956. He must have been a formidable
opponent, but Mary stood her ground.
In the 1980s, Mary, who only ever
worked with a small group, became
involved with working out the human and
mouse homology maps, alongside Har-
well and Oxford scientists, including
John Edward. This helped to lay the
foundation for the Human Genome
Sequencing Project 20 years or so later.
Mary made major advances in under-
standing the inherited effects of radiation
damage and seminal contributions to
many areas of mouse genetics, including
the t complex, embryo freezing with David
Whittingham to preserve mouse stocks,
and some early work with Richard Gard-
ner in Cambridge on mouse preimplanta-
tion embryos to determine the timing of
X inactivation.
Mary also edited Mouse News Letter
(MNL) (1956–1970); in the postwar envi-
ronment, UK and USA mouse geneticists
in particular had close and long-standing578 Cell 160, February 12, 2015 ª2015 Elsevfriendships and helped each other greatly.
MNL was an informal publication mailed
between them and other groups world-
wide, providing each other with informa-
tion about novel mutants and linkage
groups—an important ‘‘bulletin board’’ in
the pre-Internet world.
Mary won numerous awards and was
elected an FRS in 1973 and a Foreign
Associate of the US National Academy
of Sciences in 1979 but was never one
to push herself forward and did not
receive the other honors she deserved.
She was Head of Genetics at Harwell
from 1962 to 1986, when she was glad
to relinquish the increasing administrative
burden to her successor, Bruce Catta-
nach. Under her stewardship, the Ge-
netics Division had become a world-class
center and was eventually established as
the MRC Mammalian Genetics Unit, now
directed by Steve Brown. Mary continued
working productively at Harwell for many
years following her official retirement
in 1990. In 1998, Cambridge University
held a degree ceremony at which Mary
was awarded a full undergraduate de-
gree. In 2004, the Mary Lyon Centre was
opened at Harwell, in a fitting tribute to
her contributions. Rather poignantly, the
UK Genetics Society named a new medal
after Mary last year, and though she knew
of the medal, she did not live to meet its
first awardee, Loeske Kruuk. Mary was
diagnosed with Parkinson’s disease a
few years ago and died peacefully on
Christmas Day, 2014.ier Inc.Thissumsupthecareer, butnotquite the
woman. Mary was small and seemingly
quiet. When one of us (E.M.C.F.) inter-
viewed for a Ph.D position in 1983, Pete
Glenister, Mary’s long-time research
assistant, warned ‘‘not to speak in the
silences’’—the silences were Mary’s phe-
nomenal mind at work, considering the
data. When the other of us (J.P.) started
work as a lab head at Harwell in 1978,
Mary herself carried out the first set of
ENU mutagenesis injections, just to help
out. Mary had an extraordinary mind and
memory and exceptional clarity. Her mild
manner concealed an indomitable figh-
ter on research matters where she felt
strongly. She was a forward thinker and
would have been thrilled to carry out
experiments today using the panoply of
research tools now available in mice. She
also loved parties, never turning down an
invitation. She was held in great affection
by those who knew her, and she will
be missed—an intellectual colossus, just
over 5 feet tall.
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